Prescription Drug Information: Mirtazapine (Page 6 of 6)
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 7.5 mg
MIRTAZAPINE mirtazapine tablet, film coated | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
|
Labeler — NCS HealthCare of KY, LLC dba Vangard Labs (050052943) |
Establishment | |||
Name | Address | ID/FEI | Operations |
NCS HealthCare of KY, LLC dba Vangard Labs | 050052943 | repack (0615-8489) |
Revised: 09/2023 NCS HealthCare of KY, LLC dba Vangard Labs
RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.
https://rxdruglabels.com/lib/rx/rx-meds/mirtazapine-35/page/6/